Lorenzo Verderi, Silvana Pinelli, Giorgio Pelosi, Franco Bisceglie
Benzimidazole is a well-known pharmacophore present in 47 FDA-approved drugs and ≈100 experimental compounds. It shows promise for other applications, including antibacterial, antifungal, antiviral, and anticancer therapies. Many derivatives modulate oxidative stress by influencing reactive oxygen species (ROS), selectively inducing cancer cell death. Additionally, structural modificationsenhance antitumor activity and facilitate conjugation with metal centers. In this study, it is focused on the hybrid ligand 2-(1H-benzo[d]imidazol-2-yl)quinolin-8-ol (L) and its Cu(II) and Ni(II) complexes (1 and 2) as potential anticancer agents. These coordination systems are characterized, and their binding stability is assessed via UVvisible titrations and density functional theory (DFT) analysis, revealing that complex 2 is more stable than complex 1. It is then investigated how the ligand and the complexes can interact with ROS, with a view to a ROS-targeting cytotoxicity. These studies, supported by DFT, indicated that L and complex 1 are generally more interactive than complex 2. When tested on various cancer cell lines, it is found that L and complex 1 demonstrated modest to good efficacy. These results suggest that L is the primary active species, complex 1 acts as a prodrug, whereas the strong interaction with Ni(II) in 2 hinders the ligand's potential.
{"title":"Design, Optimized Synthesis, and Coordination Behavior of Quinolinic Benzimidazoles with Cu(II) and Ni(II): Reactivity Toward ROS, Computational Studies, and Biological Profiling","authors":"Lorenzo Verderi, Silvana Pinelli, Giorgio Pelosi, Franco Bisceglie","doi":"10.1002/ejic.202500395","DOIUrl":"https://doi.org/10.1002/ejic.202500395","url":null,"abstract":"<p>Benzimidazole is a well-known pharmacophore present in 47 FDA-approved drugs and ≈100 experimental compounds. It shows promise for other applications, including antibacterial, antifungal, antiviral, and anticancer therapies. Many derivatives modulate oxidative stress by influencing reactive oxygen species (ROS), selectively inducing cancer cell death. Additionally, structural modificationsenhance antitumor activity and facilitate conjugation with metal centers. In this study, it is focused on the hybrid ligand 2-(1H-benzo[d]imidazol-2-yl)quinolin-8-ol (<b>L</b>) and its Cu(II) and Ni(II) complexes (<b>1</b> and <b>2</b>) as potential anticancer agents. These coordination systems are characterized, and their binding stability is assessed via UV<span></span>visible titrations and density functional theory (DFT) analysis, revealing that complex <b>2</b> is more stable than complex <b>1</b>. It is then investigated how the ligand and the complexes can interact with ROS, with a view to a ROS-targeting cytotoxicity. These studies, supported by DFT, indicated that <b>L</b> and complex <b>1</b> are generally more interactive than complex <b>2</b>. When tested on various cancer cell lines, it is found that <b>L</b> and complex <b>1</b> demonstrated modest to good efficacy. These results suggest that <b>L</b> is the primary active species, complex <b>1</b> acts as a prodrug, whereas the strong interaction with Ni(II) in <b>2</b> hinders the ligand's potential.</p>","PeriodicalId":38,"journal":{"name":"European Journal of Inorganic Chemistry","volume":"28 35","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/ejic.202500395","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145706580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Víctor I. Noguez-Maldonado, Verónica Salazar-Pereda, Daniel Mendoza-Espinosa, Andrés Suárez, Crispin Cristobal, Manuel A. Gómez-Bonilla
The synthesis of a series of iridium(III) complexes supported by tris(pyrazolyl)borate (TpMe2) and 2-mercapto-5-(CF3)pyridine is reported. The new complexes are obtained via the treatment of the TpMe2Ir(C2H4)2 and TpMe2Ir[(η4-CH2C(Me)C(Me)CH2] precursors with equimolar amounts of 2-mercapto-5-(CF3)pyridine at room temperature. The new heteroleptic complexes display a variety of structural features including four- or five-membered iridacycles (obtained through intramolecular CS and CN bond formation) and different iridium:mercaptopyridine ratios. All new compounds are characterized by means of 1H and 13C NMR spectroscopy, elemental analyses, and by X-ray diffraction analysis. The full series of iridium(III) complexes are tested as catalysts in the transfer hydrogenation of aldehydes and ketones demonstrating good performance under low catalyst loadings (0.05 mol%) and providing good conversions. Mercury poisoning tests suggest that as the temperature of the catalytic procedure increases, the presence of a heterogeneous iridium plays an important role in the reduction process.
{"title":"Ir(III) Complexes with TpMe2 (Tris(pyrazolyl)borate) and 2-Mercapto-5-(CF3)pyridine Ligands for Transfer Hydrogenation Catalysis","authors":"Víctor I. Noguez-Maldonado, Verónica Salazar-Pereda, Daniel Mendoza-Espinosa, Andrés Suárez, Crispin Cristobal, Manuel A. Gómez-Bonilla","doi":"10.1002/ejic.202500490","DOIUrl":"https://doi.org/10.1002/ejic.202500490","url":null,"abstract":"<p>The synthesis of a series of iridium(III) complexes supported by tris(pyrazolyl)borate (Tp<sup>Me2</sup>) and 2-mercapto-5-(CF<sub>3</sub>)pyridine is reported. The new complexes are obtained via the treatment of the Tp<sup>Me2</sup>Ir(C<sub>2</sub>H<sub>4</sub>)<sub>2</sub> and Tp<sup>Me2</sup>Ir[(<i>η</i><sup>4</sup>-CH<sub>2</sub>C(Me)C(Me)CH<sub>2</sub>] precursors with equimolar amounts of 2-mercapto-5-(CF<sub>3</sub>)pyridine at room temperature. The new heteroleptic complexes display a variety of structural features including four- or five-membered iridacycles (obtained through intramolecular C<span></span>S and C<span></span>N bond formation) and different iridium:mercaptopyridine ratios. All new compounds are characterized by means of <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy, elemental analyses, and by X-ray diffraction analysis. The full series of iridium(III) complexes are tested as catalysts in the transfer hydrogenation of aldehydes and ketones demonstrating good performance under low catalyst loadings (0.05 mol%) and providing good conversions. Mercury poisoning tests suggest that as the temperature of the catalytic procedure increases, the presence of a heterogeneous iridium plays an important role in the reduction process.</p>","PeriodicalId":38,"journal":{"name":"European Journal of Inorganic Chemistry","volume":"28 35","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145706493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Walter Cañón-Mancisidor, Valentina Muñoz, Patricio Hermosilla-Ibáñez, Diego Venegas-Yazigi, Boris Le Guennic, Fabrice Pointillart, Olivier Cador
The Front Cover shows two cranes "building" hybrid complexes by placing organic fragments onto lacunary Keggin clusters, with heteroatoms (B3+, Si4+, Ge4+, P5+) highlighted by color-coded labels. A graph displays the displacement (D) and CShM distortion, with the metrics linking the interconversion between SAPR to BTPR, and vice versa. This represents how the heteroatom can control the geometry, where the X's ionic radius sets lacuna size, determining the D value and the geometry. The plot of CShM vs D shows linearity for all types of complex (mononuclear inorganic (green), mononuclear hybrid (red) and dinuclear hybrid (blue)). A D≈1.10 Å threshold separates BTPR (low D) and SAPR (high D); Ge4+/Si4+ tend to the BTPR geometry, and P5+/B3+ prefer to adopt a SAPR geometry. More information can be found in the Research Article by W. Cañón-Mancisidor, O. Cador and co-workers (DOI: 10.1002/ejic.202500074).